Evidence map›Paper›PMID 21217670›Full record

ArticleNature medicine2011

Does thrombocytopenia contribute to patent ductus arteriosus?

Kazumichi Fujioka, Ichiro Morioka, Akihiro Miwa, Satoru Morikawa, Akio Shibata, Naoki Yokoyama, Masafumi Matsuo

Registry-linked trialAbstract readCommentLetter
PubMed Publisher
In one paragraph

Article in Nature medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03022253 (Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03022253 phase3completednot on this mapstarted 2016, after this paper: background citation

Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial

TypeinterventionalSponsorPost Graduate Institute of Medical Education and Research, ChandigarhRan2016 to 2017Enrolled44ConditionsPatent Ductus ArteriosusArmsLiberal platelet transfusion, Restrictive platelet transfusion, Paracetamol, Ibuprofen
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Mouse models of patent ductus arteriosus (PDA) and their relevance for human PDA.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Review
  4. Review
  5. Article
  6. [Risk factors for patent ductus arteriosus in early preterm infants: a case-control study].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2016
    Article
  7. Predictors of successful closure of patent ductus arteriosus with indomethacin.Journal of perinatology : official journal of the California Perinatal Association · 2015
    Observational
  8. Current Perspectives on Pathobiology of the Ductus Arteriosus.Journal of clinical & experimental cardiology · 2012
    Article
  9. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Kazumichi Fujioka
Ichiro Morioka
Akihiro Miwa
Satoru Morikawa
Akio Shibata
Naoki Yokoyama
Masafumi Matsuo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsDuctus Arteriosus, PatentHumansInfant, NewbornInfant, PrematureJapanMiceModels, AnimalReproducibility of ResultsRetrospective StudiesThrombocytopenia

Identifiers

PMID21217670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.